· Periodic Report
Q3 operating profit KRW 5.2 billion, turning profitable; revenue KRW 80.3 billion
Ilyang Pharmaceutical sold KRW 80.3 billion worth in Q3 and earned KRW 5.2 billion from its main business, turning profitable from a loss a year earlier and from the previous quarter.